Cargando…
In vitro anti‐bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection
BACKGROUND: Helicobacter pylori (H. pylori) infection has become an international public health problem, and antibiotic-based triple or quadruple therapy is currently the mainstay of treatment. However, the effectiveness of these therapies decreases due to resistance to multiple commonly used antibi...
Autores principales: | Shen, Xue, Zhang, Weijia, Peng, Chang, Yan, Jiahui, Chen, Pengting, Jiang, Cheng, Yuan, Yuemei, Chen, Donglian, Zhu, Weixing, Yao, Meicun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052767/ https://www.ncbi.nlm.nih.gov/pubmed/33865425 http://dx.doi.org/10.1186/s13020-021-00442-1 |
Ejemplares similares
-
Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer
por: Zhang, Weijia, et al.
Publicado: (2022) -
A Bioactive Compound from Sanguisorba officinalis L. Inhibits Cell Proliferation and Induces Cell Death in 5-Fluorouracil-Sensitive/Resistant Colorectal Cancer Cells
por: Zhang, Weijia, et al.
Publicado: (2021) -
Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways
por: Zhang, Weijia, et al.
Publicado: (2023) -
Terpene Glycosides from Sanguisorba officinalis and Their Anti-Inflammatory Effects
por: Guo, Da-Le, et al.
Publicado: (2019) -
Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
por: Jiang, Nan, et al.
Publicado: (2021)